Cargando…
Serotonin Transporter Availability in Early Stage Parkinson's Disease and Multiple System Atrophy
Background. Differentiating Parkinson's disease (PD) from multiple system atrophy (MSA) can be challenging especially early in the course of the disease. Previous studies have shown that midbrain serotonin transporter (SERT) availability in patients with established MSA was significantly lower...
Autores principales: | Suwijn, S. R., Berendse, H. W., Verschuur, C. V. M., de Bie, R. M. A., Booij, J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945177/ https://www.ncbi.nlm.nih.gov/pubmed/24693450 http://dx.doi.org/10.1155/2014/345132 |
Ejemplares similares
-
SERT-to-DAT ratios in early Parkinson’s disease do not correlate with the development of dyskinesias
por: Suwijn, Sven R, et al.
Publicado: (2013) -
Reliability of visual assessment by non-expert nuclear medicine physicians and appropriateness of indications of [(123)I]FP-CIT SPECT imaging by neurologists in patients with early drug-naive Parkinson’s disease
por: Suwijn, Sven R., et al.
Publicado: (2019) -
Serotonin Transporter Imaging in Multiple System Atrophy and Parkinson's Disease
por: Chou, Kelvin L., et al.
Publicado: (2022) -
The diagnostic accuracy of dopamine transporter SPECT imaging to detect nigrostriatal cell loss in patients with Parkinson’s disease or clinically uncertain parkinsonism: a systematic review
por: Suwijn, Sven R, et al.
Publicado: (2015) -
Protocol of a randomised delayed-start double-blind placebo-controlled multi-centre trial for Levodopa in EArly Parkinson’s disease: the LEAP-study
por: Verschuur, Constant V. M., et al.
Publicado: (2015)